April 2020 FDA Recall Drug by H J Harkins Company Inc Dba Pharma Pac
D-1246-2020 - cGMP Deviations

This Class II drug recall was voluntarily initiated by H J Harkins Company Inc Dba Pharma Pac on April 15, 2020 for the product Drug. The FDA reported the reason for recall as cgmp deviations. The product was distributed in Product was distributed in CA and AZ. and the recall is currently terminated.

Recall Number: D-1246-2020

Reason for Recall
cGMP Deviations
Initiated
04-15-2020
Reported
04-22-2020
Quantity
9,000 tablets

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
H J Harkins Company Inc dba Pharma Pac
Product was distributed in CA and AZ.
Acetaminophen and Codeine Phosphate 300/30 mg tablet, packaged in: a) 10-count bottle (NDC 52959-0003-10), b) 12-count bottle (NDC 52959-0003-12), c) 14-count bottle (NDC 52959-0003-14), d) 15-count bottle (NDC 52959-0003-15), e) 16-count bottle (NDC 52959-0003-16), f) 20-count bottle (NDC 52959-0003-20), g) 30-count bottle (NDC 52959-0003-30), h) 60-count bottle (NDC 52959-0003-60), Rx Only, Mfg. Aurobindo; Repack: H.J. Harkins Co., Inc., Grover Beach, CA 93433

Batch or Lot Expiration Information

Lot# ATP12ZT, Exp. 05/21